800-872-2273

Clinical Trials and Studies

Study Title	Principal Investigator
A Phase 2, Open-label, Translational Biology Study of Momelotinib in Transfusion-Dependent Subjects With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF) Not recruiting \| \| Multisite View full trial information >>	Gilead Director
<< < 59 60 61 62 63 ... 65 >>